Couldn’t resist! I literally LOL’d when they mentioned Moderna; a company that will profit from the new vaccines! 🤦🏼♀️
Previously:
Tag: Moderna
German courts start examining claims over Covid jabs
German courts will from Monday begin examining a series of claims over adverse effects suffered after coronavirus vaccinations, more than two years after one of the world’s fastest and most extensive innoculation campaigns.
German courts start examining claims over Covid jabs
Video via Dr. John Campbell
COVID Infection Provides Immunity Equal to Vaccination: Study
COVID Infection Provides Immunity Equal to Vaccination: Study
Feb. 17, 2023 — The natural immunity provided by a COVID infection protects a person against severe illness on a par with two doses of mRNA vaccine, a new study says.
…
But protection against the BA.1 subvariant of Omicron was not as high – 36% at 10 months after infection, says the research team from the Institute for Health Metrics and Evaluation at the University of Washington.
The researchers examined 65 studies from 19 countries through Sept. 31, 2022. They did not study data about infection from Omicron XBB and its sub-lineages. People who had immunity from both infection and vaccination, known as hybrid immunity, were not studied.
It’s Worse Than I Thought: The Myth of Jeffrey Zients
There is no reason to trust a longtime corporate stooge to serve as President Biden’s chief of staff.
The Myth of Jeffrey Zients
Related (Archived Links):
Read More »Why India did not allow Pfizer’s Covid-19 vaccine
Why India did not allow Pfizer’s Covid-19 vaccine
In Latin America pharmaceutical bullying went a notch higher. In addition to legal indemnity, Pfizer demanded protection against their own negligence and mistakes. Argentina amended its vaccine law, three times, yet Pfizer was not happy. Pfizer wanted Argentina’s bank reserves and military bases as “guarantees”.
In the era of neo-colonialism, Pharma industry was the new East India Company.
…
Despite such pressure, India did not succumb. Eventually, Pfizer withdrew its application in 2021 We continued our vaccine programme with drugs that complied with our legal requirements.
XBB, The “Nightmare Variant” Is Here
The mainstream media is making sure we know that the XBB subvariant of Omicron is here and it’s a “nightmare”. This one, like many before it, has been “immune evasive” meaning it’ll still infect those who have already had COVID-19 or have been given five injections to prevent it.
XBB, The “Nightmare Variant” Is Here
No Accountability for Pfizer as Bourla Ignores EU Covid Committee Hearings
Pfizer CEO backs out of EU COVID committee hearing
No Accountability for Pfizer as Bourla Ignores EU Covid Committee Hearings
New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble
VERIFY: New COVID booster approved from final study of mice, not humans
According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”
The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”
…
“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”
Related:
Read More »Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot
The Biden administration today said it made available 10 million doses of COVID-19 vaccines for children under age 5 to states and healthcare workers with “millions more available in the coming weeks.”
Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot
1,287,595 Injuries Reported After COVID Shots, Vaccine Injury Compensation Programs ‘Overwhelmed’
VAERS data released Friday by the Centers for Disease Control and Prevention show 1,287,595 reports of adverse events from all age groups following COVID-19 vaccines, including 28,532 deaths and 235,041 serious injuries between Dec. 14, 2020, and May 27, 2022.
1,287,595 Injuries Reported After COVID Shots, Vaccine Injury Compensation Programs ‘Overwhelmed’
Ms. Cat’s Chronicles 
You must be logged in to post a comment.